Better Therapeutics (BTTX) Competitors $0.0001 0.00 (-50.00%) As of 05/21/2025 01:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock BTTX vs. UPHL, ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, and NTRAShould you be buying Better Therapeutics stock or one of its competitors? The main competitors of Better Therapeutics include UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), and Natera (NTRA). These companies are all part of the "healthcare" industry. Better Therapeutics vs. UpHealth Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings, community ranking and profitability. Which has higher valuation and earnings, UPHL or BTTX? Better Therapeutics has lower revenue, but higher earnings than UpHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpHealth$130M0.00-$56.42M-$1.350.00Better TherapeuticsN/AN/A-$39.76MN/AN/A Does the MarketBeat Community believe in UPHL or BTTX? Better Therapeutics received 5 more outperform votes than UpHealth when rated by MarketBeat users. CompanyUnderperformOutperformUpHealthN/AN/ABetter TherapeuticsOutperform Votes541.67% Underperform Votes758.33% Does the media prefer UPHL or BTTX? In the previous week, UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score. Company Overall Sentiment UpHealth Neutral Better Therapeutics Neutral Do institutionals and insiders hold more shares of UPHL or BTTX? 56.1% of UpHealth shares are held by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Comparatively, 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is UPHL or BTTX more profitable? Company Net Margins Return on Equity Return on Assets UpHealthN/A N/A N/A Better Therapeutics N/A N/A N/A Which has more volatility and risk, UPHL or BTTX? UpHealth has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. SummaryBetter Therapeutics beats UpHealth on 4 of the 6 factors compared between the two stocks. Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTTX vs. The Competition Export to ExcelMetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$5,000.00$825.71M$5.33B$8.39BDividend YieldN/A2.30%5.21%4.11%P/E RatioN/A50.9126.7119.71Price / SalesN/A11.58386.12120.59Price / CashN/A26.1438.2534.62Price / BookN/A3.836.774.50Net Income-$39.76M-$5.50M$3.23B$248.22M7 Day PerformanceN/A5.12%1.80%0.56%1 Month PerformanceN/A81.93%11.10%13.17%1 Year PerformanceN/A19.80%17.11%7.30% Better Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTTXBetter TherapeuticsN/A$0.00-50.0%N/A-99.1%$5,000.00N/A0.0040Gap DownUPHLUpHealthN/A$0.00flatN/A-99.9%$4,000.00$130M0.001,750ACONWAclarionN/A$0.04flatN/A+23.0%$0.00$45,724.000.007Positive NewsAONCAmerican Oncology NetworkN/A$6.95flatN/A+258.8%$0.00$1.34B0.001,520Gap UpDHACWDigital Health AcquisitionN/A$0.04+1.1%N/AN/A$0.00N/A0.00N/AGap UpLFMDPLifeMDN/A$24.40+0.2%N/A+16.5%$0.00$234.01M0.00230News CoverageOTRKPOntrakN/A$0.23+2.0%N/A-26.7%$0.00$10.84M0.00250News CoveragePositive NewsPIIIWP3 Health PartnersN/A$0.01-8.9%N/A-82.6%$0.00$1.50B0.00500TALKWTalkspaceN/A$0.11flatN/A-33.1%$0.00$194.36M0.00500Gap UpTOIIWOncology InstituteN/A$0.08-12.8%N/A-22.2%$0.00$393.41M0.00660Positive NewsGap DownNTRANatera3.2746 of 5 stars$154.53+0.8%$182.12+17.9%+39.6%$21.10B$1.83B-87.803,020Positive News Related Companies and Tools Related Companies UPHL Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTTX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.